Apragem 1gm Ready-to-Use Injection – Effective Solution for Medical Needs

Apragem 1gm RTU Injection

Description

Apragem 1gm RTU Injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat:

• Bladder cancer (in combination with cisplatin);
• Ovarian cancer (in combination with carboplatin);
• Breast cancer (in combination with paclitaxel);
• Pancreatic cancer;
• Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin.

Mechanism of Action

The injection blocks the ability of cancer cells to process DNA replication, which is essential for the cells to divide and grow. This can prevent or stop the growth of cancer cells.

Dosage and Administration

Apragem 1gm RTU Injection is administered as an intravenous infusion into the vein. The dosage and administration frequency are chosen by the physician based on the medical condition, as it differs for each person. Do not self-administer.

Safety Advice

• Pregnancy: Apragem 1gm RTU Injection can cause harm to your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.
• Breastfeeding: You must not breastfeed while being treated with Apragem 1gm RTU Injection. Inform your doctor if you are breastfeeding before taking this injection.
• Lungs: Apragem 1gm RTU Injection is used cautiously in a patient with a lung disorder. Inform your doctor if you have any lung disease.
• Liver: You need to tell your doctor if you have any liver disorders before taking Apragem 1gm RTU Injection. Your doctor may decide to adjust the dose or delay treating you depending on your liver function.
• Alcohol: It is not advised to take alcohol while under this treatment because Apragem 1gm RTU may cause drowsiness and sleepiness.
• Driving: Apragem 1gm RTU Injection could affect your ability to drive. Avoid driving while taking this medicine.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

• Serious:
  • Pulmonary toxicity (shortness of breath, wheezing, cough);
  • Hemolytic-uremic syndrome (changes in the volume or colour of urine, increased bruising, or bleeding);
  • Pain or tenderness in the upper abdomen;
  • Allergic reactions, rashes, fever, swelling or sores in the mouth.
• Common:
  • Nausea, vomiting;
  • Low blood cell count;
  • Loss of appetite;
  • Hair loss;
  • Swelling of ankles, feet, and fingers;
  • Insomnia;
  • Constipation, diarrhea;
  • Headache;
  • Runny nose, chills;
  • Muscle pain, back pain;
  • Sweating;
  • Liver problems;
  • Blood in urine;
  • Abnormal urine test;
  • Oedema (swelling of ankles, fingers, feet, face).

Interactions

Inform your healthcare professional about all the medicines you take, including prescription medications, over-the-counter medications, nutritional and vitamin supplements, and herbal products. Certain medications interacting with Apragem 1gm RTU may reduce effectiveness by causing undesirable side effects.

Storage

This medicine does not require any special storage conditions. Do not refrigerate or freeze. Keep Apragem 1gm RTU Injection out of sight and reach of children.

FAQ

1. How does Apragem 1gm RTU affect cancer cells differ from healthy cells?

   • Apragem 1gm RTU affects cancer cells more than healthy cells because cancer cells have a higher rate of DNA synthesis and replication than healthy cells. Apragem 1gm RTU interferes with this process, which is essential for cancer cell growth and division, ultimately leading to the death of cancer cells.

2. Can Apragem 1gm RTU be used to treat cancer in children?

   • No, Apragem 1gm RTU injection is not recommended for adolescents and children under the age of 18.

3. What should I tell my doctor before starting Apragem 1gm RTU treatment?

   • Patients should inform their doctor of any pre-existing medical conditions, allergies, or medications they are taking before starting Apragem 1gm RTU treatment. It is also important to inform the doctor if you are pregnant, planning to become pregnant, or breastfeeding.

4. Are there any dietary or lifestyle changes that patients should make while taking Apragem 1gm RTU?

   • Patients may need to make dietary or lifestyle changes while taking Apragem 1gm RTU, such as avoiding certain foods or activities that may interfere with the medication's effectiveness or cause side effects. This should be discussed with a healthcare professional.

5. Does Apragem 1gm RTU cure cancer?

   • Apragem 1gm RTU can help slow the growth and spread of cancer cells, but it may not cure cancer on its own. It is often used in combination with other treatments, such as surgery, radiation therapy, or other chemotherapy medications, to improve the chances of a cure or long-term remission.

6. How long does Apragem 1gm RTU treatment last?

   • The duration of Apragem 1gm RTU treatment will depend on the type and stage of the cancer being treated, as well as the patient's overall health and response to the medication. Treatment may last several weeks or months.

Fact Box

• Molecule name: Gemcitabine.
• Therapeutic class: Anti-Cancer.
• Pharmacological class: Antimetabolites.
• Indications:
  • Bladder cancer, in combination with cisplatin;
  • Ovarian cancer, in combination with carboplatin;
  • Breast cancer, in combination with paclitaxel;
  • Pancreatic cancer;
  • Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin.

Tags: medical-injection, drug-product, pharmaceutical, rtu-injection, 1gm-dose